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cancerous mice that did not, and were found
to have tumors less than halfthe size ofthose
in the untreated mice. The researchers showed
the method to be effective against a wide
range of tumors, including those caused by
inoculating mice with human lung, colon,
breast, kidney, and liver cancers. The
Salmonella even effectively battled multiple
tumors within the same animal, the
researchers reported in the 15 October 1997
issue ofCancerResearch.
The mechanism by which bacterial infec-
tions slow cancer growth is not known, but
investigator John Pawelek and colleagues
Brooks Low and David Bermudes at Yale rea-
soned that ifsuch an infection was localized to
the tumor site, it would slow the cancer
growth more effectivelywhile reducing the risk
of infection elsewhere in the body. By using
different growth substrates, the team was able
to isolate a mutant form of Salmonella that
needs an unusual mix of metabolites to
grow-a mix found in abundance within
malignant tumors but scarcely anywhere else
in the body. Once injected into a cancerous
mouse, the mutant Salmonella seeks out the
tumor and thrives there, while the immune
system easilycontrols the bug in the rest ofthe
body. Sacrificed mice that had undergone
treatment had Salmonella populations in their
tumors that were 250-9,000 times as dense as
thosefound in theanimals' livers.
The deliberate infections dramatically
reduced tumorgrowth, but the authors decid-
ed to take the research a step further. They
reasoned that, because their Salmonella strain
tended to concentrate itselfaround tumors, it
would make agoodvehide fordelivering anti-
cancer drugs. In this vein, the researchers fur-
ther modified the strain by introducing into
the bacteria the herpes simplex virus gene that
codes for thymidine kinase. While thymidine
kinase does not fight cancer on its own, it is
deadly to cells when combined with ganci-
dovir, a prodrug used to fight herpes inAIDS
patients. By a verypoorly understood process,
cells that produce thymidine kinase, such as
the Yale team's modified Salmonella, will not
only die upon contact with gancidovir, they
will take their nearest neighbors with them.
This so-called "bystander effect," which was
first noted a decade ago, has been observed in
many instances ofcell death.
The researchers injected mice with the
Salmonella that incorporated the thymidine
kinase gene, and then treated them with gan-
ciclovir. As expected, additional tumor regres-
sion due to the bystander effect was noted.
However, the researchers reported, this effect
was small in comparison to the much more
radical effect ofthe bacterial infection on the
tumor, despite the efficacy of the drug.
Nonetheless, the use of Salmonella as a drug
delivery device still represents an important
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Salmonella soldiers? Mice injected with Salmonella show that the bacteria make their way into
melanoma tumor cells and multiply, slowing the growth of the tumor.
breakthrough. Getting drugs into tumors has
always been a difficult challenge for doctors
because, among other barriers, tumors have
high internal pressure pushing outward. But
the Yale scientists showed that for motile
Salmonellasuchobstacles areno problem.
The October report bytheYale group was
the culmination offour years of research on
this radical new method to fight cancer. Now
the scientists are preparing the invention for
use in clinical trials, the next step in drug
development.
Is Airborne Manganese a
Hazard?
Public health officials, scientists, and regula-
tors worry that a gasoline additive containing
manganese, claimed by its maker to boost
engine performance, may cause physical harm
by increasing the amount ofmanganese in the
air. Ethyl Corporation of Richmond,
Virginia, which makes methylcyclopentadi-
enyl manganese tricarbonyl (MMT), disputes
such worries, and says the manganese emitted
into the air when MMT is burned poses no
riskto human health.
The concerns about the additive come as
the Agency for Toxic Substances and Disease
Registry (ASTDR) is completing a toxicologi-
cal profile of manganese to assess sources of
exposure and the metal's impact on health.
The agency is required to prepare such pro-
files for hazardous substances found at the
nation's most serious hazardous waste sites-
those on the EPA's National Priorities List of
Superfund sites. Of1,430 sites on thelist, 644
(or 45%) have "excessive levels of man-
ganese," according to the ATSDR. Excessive
levels are those greater than background in the
environment.
A trace element, manganese is an essential
part of the diet and can easily be obtained
from grains and nuts. Manganese deficiency
can lead to bone problems and stunted
growth. Excess dietary manganese is simply
excreted. A number of studies have shown
that occupational exposure to manganese can
lead to Parkinson's disease-like symptoms
such as musde tremors.
Manganese is used to give strength to steel
and aluminum. Manganese levels in the air
can vary widely, being higher near foundries
and metal plants and lower away from such
facilities. But it's chronic exposure to man-
ganese compounds emitted in the exhaust of
vehides fueled by MMT-boosted gas that has
raised the most concerns.
Canada banned the import ofMMT this
year-none ofthe additive is made there-due
to concerns over possible health effects. MMT
had been used in Canadian gasoline for nearly
20 years. Ethyl is fighting the ban. A U.S.
appeals court in Washington, DC, overturned
an EPA ban on MMT in 1995, saying the
agency acted illegally by attempting to ban the
additive on health grounds under the Clean Air
Act (CAA). The court said that under the CAA,
the EPA could only consider MMYs effect on
engine performance. But California has success-
fully kept the additive out ofunleaded gasoline
sold in that state for approximately 20 years
because ofa "lack ofdata on thehealth effects of
breathing manganese," says Richard Vincent, a
spokesmanfortheCaliforniaAirResourcesBoard.
Widespread exposure to manganese, says
Michael Davis, senior health scientist and act-
ing chief of the EPA's Hazardous Pollutant
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Assessment Branch, may cause neurological
damage, as well as harm to the lungs and the
reproductive system. "We didn't feel like
those areaswere adequatelyevaluated [in con-
sidering exposure from MMT]," he says.
Davis notes studies that show workers who
were occupationally exposed to manganese
were subject to pneumonia and coughs. He
also cites a 1973 study that suggested an
increase in respiratoryillnesses inJapanese stu-
dentslingnearafctryemitngmangnese
Adrafttoxicological profile formanganese
preparedbytheATSDRcites studies showing
that men occupationally exposed to man-
ganese have impaired fertility as well as impo-
tence andloss oflibido. However, data on the
health effects of manganese exposure are
scantyandincondusive, accordingtotheprofile.
Moreover, says Monica Campbell, a
Toronto toxicologist andspokesperson for the
Ontario Public Health Association, studies of
MMT have failed to consider the impact of
manganese from MMT on people living near
major arterial roads. They are a vulnerable
population more exposed to vehide exhausts,
shesays.
Astudy oflaboratory rats, presented at the
Arkansas conference by researchers Hans
Tjalve and Jorgen Henriksson ofthe Swedish
University ofAgricultural Sciences in Uppsala,
found that, when inhaled through the nose,
manganese can enter the brain and reach the
spinal column. Says EPA neuroscientist
Kenneth Hudnell, "This is awhole new route
ofexposurethathasn'tbeen considered before.
Itbypassesallprotectivebarriersthatwehave."
And in an EPA-funded study, Donna
Mergler, aneurophysiologist at the Universite
du Quebec atMontreal, andcolleagues found
arelationship betweenmanganese levels inthe
blood and neuromotor slowing problems in
peoplewho lived near, but did notwork'in, a
former manganese alloy production plant.
Higher blood manganese levels were also
linked to learning and memory problems in
men over theageof50. But thefindings from
this research are preliminary, cautions
Hudnell, who was a researcher on the study.
"It simply points out the need for more
research," hesays.
Donald Lynam, an Ethyl vice president
and scientist, takes a different view. Lynam
says that MMT adds virtually no manganese
to the air. He points to the condusions ofan
Ethyl-sponsored study, also presented at the
Arkansas conference, that found that MMT's
contribution of manganese to the air in
Torontowas trivial.
He further points to a review by the
Canadian agency Health Canada that con-
dudes thatitisimpossible to assesstheimpact
ofMMT on manganese in the air. The 1994
review, however, did recommend monitoring
for MMT because use of the additive has
increasedsubstantially inrecentyears.
Ethyl's position on the potential health
hazards ofmanganese generated by MMT is
unambiguous. According to a statement on
the Ethyl Web site, "`[No evidence exists sug-
gesting that MMT presents any risk to public
health, muchlessasignificant risk."
Meanwhile, MMT can be and is being
added to gasoline in the United States.
According to the EPA, MMT was added to
11 million gallons ofgasolineduringthesum-
mer of 1997. That is an extremely small por-
tion ofthe billions ofgallons ofgas that are
sold each year, according to the agency. But
the EPA's concern overthe manganese MMT
puts into the air isn't assuaged. The agency is
still talking with Ethyl Corporation to decide
what types ofhealth effects testing it wants
done on animals exposed to the manganese
generatedwhenMMTisburned ingasoline.
NewTestSpeeds Detection of
E. co/i
A mutant form of Escherichia coli called
0157:H7 continues to make headlines for
causing sometimes-fatal illnesses in those who
eat contaminated foods. Three children died
inWashington State in 1993 aftereating con-
taminated hamburgers at a Jack-in-the-Box
fast food restaurant. In the summer of 1997,
25 million pounds ofhamburger, potentially
tainted with E coli 0157:H7, were recalled
by Hudson Foods in Columbus, Nebraska,
aftermakingconsumersill.
The present way to detect E. coli
0157:H7 requires growing the bacteria in
laboratory cultures, which takes days. And
some stubborn bacteria refuse to grow in the
laboratory, yet still infect people, giving false-
negative results. This time-consuming and
inaccurate method limits the detection ofdis-
ease-causing bacteria.
Now, Montana researchers have created a
new technique that detects E co/i0157:H7 in
four hours, is highly sensitive, and works in
food, feces, and water. The method could be
adapted to detect other foodborne pathogens
such as Salmonel4, or even biological warfare
agents. "Youcan usethismethodonanyorgan-
ism. It's not just for E. coli," says Gordon
McFeters. He and fellow microbiologist Barry
Pyle ofMontana State University in Bozeman
invented the technology with funds from the
NationalAeronautics andSpaceAdministration
(which is looking for new ways to check the
safety offood and water on space missions),
then teamed up with Montana ImmunoTech,
Inc., inBozenantoperfecttheirtest.
The patent-pending technology uses anti-
bodies to detect unique molecules on the sur-
face ofE. coli 0157:H7. The antibodies are
attached to tiny (0.1 micron) magnetic beads
that bind bacteria, then are concentrated by
passing them through amagnet beforesuiining
withfluorescentdyesfordetection. Inlaborato-
ry trials, as few as 10 E. C0o/ 0157:H7 bacteria
were detected in slurried samples ofraw ham-
burger. "The organism is so virulent, just ten
can cause an infection," says immunologist
John Jutila, president of Montana
Immunotech. The magnetic beads are also
coatedwith antibodies that detect the toxins or
virulence factorsproduced byE co/i0157:H7,
makingthetestdoublydiscriminating.
With a new two-year $750,000 Small
Business Innovation Research (Phase II) grant
from the National Institutes ofHealth, the
researchers will convert the prototype anti-
body/bead method into an easy-to-use dip-
stick test for field use. The prototype requires
cumbersome laboratory equipment such as a
fluorescent microscope. The researchers face
thechallengeofapplying theirtechnology to a
dipstick. "The dipstick technology is con-
ceived and under development," says Pyle.
Once perfected, a dipstick, similar to a home
pregnancy kit, could check feces ofcattle at
slaughterhouses to stop infected animals from
slipping in. Or farther along, meat ground at
local supermarkets could be checked before
beingpackagedforconsumers.
Microbiologist Dick Wilson, director of
the E. coli reference center at Penn State
University in UniversityPark, an international
repository holding 34,000 strains, says that a
test kit for E coli0157:H7 should be highly
specific and sensitive, rapid, and eliminate the
need for ahigh-tech laboratory. He's watched
the development ofa burgeoning number of
such kits and the Montana technology stands
out, he says, because it also detects virulence
factors. "An increasing number of E. coli
strains with the same virulence factors as
0157:H7 are evolving and infecting animals
andpeople," saysWllson.
In designing their dipstick for field use,
the Montana team needs to overcome two
possible limitations, says Wilson. First, the
dipstick must be highly sensitive to detect
small numbers ofinfectious bacteria, and sub-
stances in food, water, and feces must not
interfere with the antibody binding. Second,
little has been determined about the environ-
mental ecology ofE. coli 0157:H7 since it
first appeared in 1982. No one knows how
cattle become infected with E. co/i 0157:H7
before passingit to people. Tom Besser, avet-
erinarian and microbiologist at Washington
State University's College of Veterinary
Medicine in Pullman, suspects water or feed
are contaminated, because outbreaks in cattle
herds resemble foodborne epidemics. A dip-
stick could help track the source ofE. coli
0157:H7 on farms and eliminate it. "This
area has received little attention," says Besser.
Ifcontaminatedwater proves to be the source,
"we could learn how to design or clean tanks
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